Clinical Trials Logo

X Fragile Syndrome clinical trials

View clinical trials related to X Fragile Syndrome.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04768803 Recruiting - Epilepsy Clinical Trials

Ghrelin in Patients With a Rare Disease Associated With Intellectual Disability, and Hyperphagia, and/or Overweight, and/or Obesity

HOGRID
Start date: June 10, 2021
Phase:
Study type: Observational [Patient Registry]

A significantly higher proportion of patients with rare diseases (RD) with intellectual disability (ID), present hyperphagia, overweight or obesity, compared to the general population. Prader-Willi syndrome is the only genetic obesity identified to date associated with hyperghrelinemia, while ghrelin levels are lower than in controls in other situations of obesity. The aim of the study is to find out whether the levels of ghrelin, which are abnormally high in PWS throughout life, are also high in these RD when people have hyperphagia and/or overweight.